3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Prostatic Neoplasms
2
Glioma
2
Glioblastoma
2
Weight Loss
1
Triple Negative Breast Neoplasms
1
Thrombocytopenia
1
Splenomegaly
1
Sarcoma, Kaposi
1
Oligodendroglioma
1
Multiple Myeloma
1
Lymphocytosis
1
Lymphadenopathy
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hodgkin Disease
1
HIV Infections
1
Gliosarcoma
1
Fever
1
Fatigue
1
Ependymoma
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Neoplasms
1
Brain Neoplasms
1
Astrocytoma
1
Anemia
1
Acquired Immunodeficiency Syndrome
1
Interventions
Tobacco Use Cessation Devices
2
Surveys and Questionnaires
2
Nivolumab
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
Electrocoagulation
2
Biopsy
2
fludarabine phosphate
1
fludarabine
1
Watchful Waiting
1
Trichloroacetic Acid
1
Transurethral Resection of Prostate
1
Tomography, X-Ray Computed
1
Thiotepa
1
Therapeutics
1
Tacrolimus
1
Self Care
1
Ritonavir
1
Registries
1
Rapid Diagnostic Tests
1
Proctoscopy
1
Papillomavirus Vaccines
1
Occult Blood
1
Observation
1
Nevirapine
1
Methylprednisolone Hemisuccinate
1
Methylprednisolone
1
Melphalan
1
Mass Screening
1
Mammography
1
Lopinavir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Acquired Immunodeficiency Syndrome
×
Ritonavir
×
Clear all
NCT00444379
2014-08-20
ARKS
University of California, San Francisco
Phase 4
Completed
224 enrolled